Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

Share Price is delayed by 15 minutes
Get Live Data
190.00    3.00 (1.62%)
Bid:
185.00
Ask:
195.00
Spread: 10.00 (5.405%)
Market Cap: £99.47m
SOM Live PriceLast checked at - London Stock Exchange

Intraday Somero Share Chart

Trading Statement

27 Jan 2009 07:00

RNS Number : 2736M
Somero Enterprises Inc.
27 January 2009
 



January 27, 2009

Somero Enterprises, Inc ®

("Somero" or "the Group")

Period End Trading Update

The Board of Somero Enterprises, Inc®, the North American manufacturer of patented laser guided equipment used for the spreading and leveling of high volumes of concrete for floors in the construction industry, is pleased to confirm that revenues and earnings for the year to 31 December 2008which included significant restructuring charges, were in line with its expectations. 

The credit crisis has slowed sales in most countries where Somero does business with the exception of China and the Middle East, which exceeded expectations and continue to offer opportunities for growth

The major cost reduction programme implemented by the Group in 2008 has been very effective and will, in aggregate, result in a reduction in SG&A expenses of c.42% for 2009, significantly ahead of the 30% reduction announced in November 2008 The Group's balance sheet remains strong, with a reduced year end net debt level of under $10m.

Jack Cooney, CEO of Somero commented:

"The effect on construction activity of the sudden and extensive worldwide shutdown of the credit markets was mitigated by the swift action taken in November to further reduce costs. We recognised the impact on our customers very early in the process and have made significant reductions to our cost structure in the US and EuropeThe Group is now at an appropriate size given the current market, however, despite major cost reductions, we continue to invest in China and the Middle East to take advantage of growth opportunities.

"Our ability to move quickly has allowed us to renegotiate our loan agreement to provide significant flexibility in the coming years. Despite unprecedented times, the management remains confident that the fundamentals of the Group remain strong and that the strategies in place combined with the Group's market leading position will result in continued long-term growth for Somero." 

Somero will report full year results in early May 2009.

-ends-

Enquiries:

Financial Dynamics

+44 (0)20 7831 3113

Juliet Clarke / Erwan Gouraud

Hawkpoint Partners

+44 (0)20 7665 4500

Christopher Kemball / Chris Robinson

Collins Stewart

+44 (0)20 7523 8000

Piers Coombs

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQQLFLKFBEBBD
Date   Source Headline
5th Jun 20267:00 amRNSAGM Statement
4th Jun 20267:47 amRNSTransaction in Own Shares and Total Voting Rights
2nd Jun 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
28th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
20th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
14th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
8th May 20262:53 pmRNSHolding(s) in Company
7th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Apr 20265:39 pmRNSUpdate regarding Company Shareholdings
30th Apr 20261:44 pmRNSTransaction in Own Shares and Total Voting Rights
30th Apr 20267:00 amRNSNotice of AGM & Director Succession Update
27th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Apr 20267:00 amRNSHolding(s) in Company
21st Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Apr 20269:08 amRNSHolding(s) in Company
9th Apr 20267:00 amRNSBuyback Expansion and Further M&A Framework Detail
9th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Mar 20265:27 pmRNSHolding(s) in Company
30th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Mar 20269:01 amRNSHolding(s) in Company
26th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Mar 20267:00 amRNSHolding(s) in Company
24th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Mar 20267:00 amRNSLaunch of 2026 Share Buyback Programme
12th Mar 20267:00 amRNSLaunch of 2026 Share Buyback Programme
10th Mar 20267:00 amRNSFinal Results
17th Feb 20267:00 amRNSNotice of Investor Presentation
29th Jan 20267:00 amRNSTrading Update
20th Jan 20267:41 amRNSHolding(s) in Company
19th Dec 20252:28 pmRNSTransaction in Own Shares and Total Voting Rights
19th Dec 20252:28 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Dec 20251:30 pmRNSTransaction in Own Shares and Total Voting Rights
5th Dec 20257:00 amRNSHolding(s) in Company
4th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Nov 20259:01 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.